Testimony, Comments, & Letters

2024

March

Research!America Letter to Centers for Medicare and Medicaid Services on Research Data Request and Access Policy Changes

February

Research!America Comment Letter on NIST Request for Information (RFI) Regarding the Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights

January

Research!America Letter on Bicameral Passage of a Continuing Resolution

Research!America Requesting Extension -Request for Information Regarding the Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights

2023

November

• Letter from Research!America to All Senators Urging Floor Vote on the Confirmation of Dr. Monica Bertagnolli to Serve as NIH Director
• Letter from Research!America to Senate Leadership Urging Floor Vote on the Confirmation of Dr. Monica Bertagnolli to Serve as NIH Director 

October

• Letter From Research!America to Senator Cassidy on the NIH Reauthorization Request for Information
• Letter From Research!America on the Office of Pandemic Preparedness and Response 

July

• Letter from Research!America to NIH Director on Guidance for Subaward/Consortium Written Agreement

May

• Letter From Research!America to President Biden and Congressional Leaders, May 25, 2023

2022

October

• Letter to Senate Leadership Urging Action on the PREVENT Pandemics Act (S.3799), October 27

September

• Sign-on Letter on FY23 Appropriations, September 19, 2022
• Letter from Research!America to President and Leadership on User Fees

July

• Letter to Congressional Leadership on SBIR/STTR Reauthorization, July 21, 2022

June

• Letter to the President on NIH Director Appointment, June 22, 2022

May

• Sign-on Letter on FY23 Appropriations 302(b) Allocations, May 16, 2022

April

• Research!America Letter to Congressional Leaders Urges Passage of COVID-19 Funding

March

• Letter to White House and Congressional Leadership on COVID-19 Research, March 17, 2022
• Letter to Senators Murray and Burr, March 14, 2022
• Letter to HHS Secretary Becerra on Bayh-Dole, March 3, 2022

January

• Letter to Congressional Leadership on Omnibus Appropriations, January 11, 2022

2021

November

• Letter to Congressional Leadership

September

• Letter to Congress on Drug Pricing

August

• Comments for NIH and OSTP listening session on the proposed ARPA-H, August 4, 2021

July

• Research!America Letter to Sens. Leahy and Shelby 7.22.21

May

• Testimony to the House Committee on Appropriations Subcommittee on Labor, Health and Human Services, Education on FY22 Appropriations

March

• Sign-on Letter to President Biden on the RISE Act

February

• Letter to Congressional Leadership, February 3, 2021

January

• Letter to President-Elect Biden and Vice President-elect Harris
• Letter to President Biden on the Acting FDA Commissioner

2020

December

• Sign-on Letter to Leader McConnell and Speaker Pelosi

October

• Letter to House Select Subcommittee on the Coronavirus Crisis, October 29, 2020 
• Letter to Speaker Pelosi and Secretary Mnuchin, October 19, 2020
• Letter on Supplemental Spending, October 1, 2020

September

• Letter to Congressional Leadership, September 17, 2020

August

• Letter to Congressional Leadership, August 20, 2020
• Letter to Congressional Leadership, August 5, 2020

July

• Letter to HELP Committee, July 20, 2020
• Letter to Congressional Leadership, July 16, 2020
• Letter to President Trump, July 15, 2020
• Letter to "Labor-H" Appropriations Subcommittee, July 2, 2020

June

• Letter to Representatives Degette and Upton in Support of Cures 2.0, June 18, 2020
• Letter to Congressional Leadership, June 16, 2020

May

• Testimony of Research!America to the Senate Committee on Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies Concerning Fiscal Year 2021 Appropriations for NIH, CDC, and AHRQ Submitted for the Record, May 20, 2020
• Comments on Supplemental Notice of Proposed Rulemaking to the Rule “Strengthening Transparency in Regulatory Science”
• Letter to Secretary Azar Regarding EcoHealth Alliance Grant, May 12, 2020
• Testimony of Research!America to the Senate Committee on Appropriations Subcommittee on Commerce, Justice, Science, and Related Agencies Concerning FY21 Appropriations for NSF, May 4, 2020

April

• Letter to Congressional Leadership, April 30, 2020
• Multisociety Letter Regarding Discrimination Against People of Asian Descent
• Letter to Appropriations Leadership
• Testimony of Research!America to the Senate Committee on Appropriations Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies

March

• Testimony of Research!America to the House Committee on Appropriations Subcommittee on Commerce, Justice, Science, and Related Agencies Concerning FY21 Appropriations for NSF

2019

December

• Letter to Leadership on Completing FY20 Appropriations Process

October

• Letter to Congressional Leadership on Continuing Resolutions

September

• Letter on FY20 Appropriations

July

• Letter of Support for H.R. 3877, Bipartisan Budget Act
• Letter of Support for H.R. 3038, Securing American Science and Technology Act of 2019
• Letter to White House and Congressional Leadership Urging Action  on a Budget Deal

June

• Letter of Support for Pocan Amendment

May

• Letter from Coalitions representing 500 combined member organizations regarding budget caps
• Letter to House and Senate Leadership regarding Budget Caps
• Letter to Homeland Security and Government Affairs Committee regarding FACA

April

• Testimony of Research!America to the Senate Committee on Appropriations Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Concerning Fiscal Year 2020 Appropriations for FDA

March

• Testimony of Research!America to the House Committee on Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies
• Letter to Senate Leadership in response to Request for Information on ways to reduce healthcare spending

February

• Open Letter to Congress and the President of the United States on Harm to American Science from Shutdown

January

• Letter to Senate Leadership in acknowledgement of confirmation of OSTP Director Dr. Kelvin Droegemeier

2018

November

• Letter to House and Senate Leadership on Completing FY19 Appropriations

October

• Research Community Thank You Letter to Labor-HHS Leadership on FY19 Conference Report 

July

• Letter to Senate Labor-HHS Subcommittee Leadership on FY19 appropriations request for NIH, CDC and AHRQ

June

• Letter to Senate and House Leadership from Research!America and the Network for Excellence in Health Innovation (NEHI) regarding the proposed rescissions package

May

• Letter from Research!America on 302(b) Allocations
• Letter to Senate and House Leadership regarding rescissions package
• Letter to Senate Finance Committee and House Ways and Means Committee Leadership regarding rescissions package
• Letter to Senate and House Appropriation Committee Leadership regarding 302(b) allocations

April

• Letter to Senate and House Labor-H Committee Leadership regarding FY18 appropriations

February

• Joint Letter from Research Leaders to Senate and House Leadership regarding 302(b) allocations 
• Letter to Senate and House Leadership and Appropriations Committee Leadership regarding FY18 appropriations request

January

• Letter to Senate and House Leadership regarding the opioid crisis
• Letter to Senate and House Appropriations Committee Leadership regarding FY18 appropriations request

2017

November

• Letter to Senate and House Leaders regarding FY18 budget 

September

• Letter to Senate Leadership on Prevention and Public Health Fund

July

• Letter to Senate and House Leaders regarding FY18 sequestration 

March

• Letter to Members of the Senate and House Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies on FY17 Appropriations
• Letter to Members of the Senate and House Subcommittee on Labor, Health and Human Services, Education, and Related Agencies on FY18 Appropriations 
• Letter to Members of the Senate and House Subcommittee on Commerce, Justice, Science, and Related Agencies on FY18 Appropriations
• Testimony to the House Committee on Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies Concerning Fiscal Year 2018 Appropriations for NIH, CDC, and AHRQ 

February

• Letter to Members of Congress regarding Research!America's FY18 Appropriations Request

January

• Letter to Senate and House leaders on FY17 and FY18 appropriations

2016

November

• Letter to Paul Ryan on continuing resolution for FY17 
• Letter to Senate and House leaders on 21st Century Cures legislation
• Letter to Senate and House leaders on FY17 appropriations bills

October

• Letter to Senate and House leaders on 21st Century Cures legislation

July

• Letter to the Senate and House leaders on Zika funding

May

• Letter to Republican National Committee Chairman Reince Priebus to include investments in public health in the Republican Party Platform
• Letter to Democratic National Committee Chairwoman, The Honorable Deborah Wasserman Schultz to include investments in public health in the Democratic Party Platform

April

• Letter to the Senate Committee on Health, Education, Labor and Pensions on Innovations legislation
• Letter to the Senate Subcommittee on Labor, Health and Human Services, Education, and Related Agencies on FY17 appropriations for NIH, CDC, and AHRQ
• Letter to the House Subcommittee on Labor, Health and Human Services, Education, and Related Agencies on FY17 appropriations for NIH, CDC, and AHRQ

February

• Letter to the House Subcommittee on Commerce, Justice, Science, and Related Agencies to increase funding for the NSF in the FY17 budget
• Letter to the House Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies to increase funding for the FDA in the FY17 budget
• Letter to the Senate Committee on Labor, Health and Human Services, Education, and Related Agencies to increase funding for NIH, CDC and NIH in the FY17 budget
• Letter to the House Committee on Labor, Health and Human Services, Education, and Related Agencies to increase funding for NIH, CDC and NIH in the FY17 budget

2015

November

• Letter to the House Committee on Ways and Means and Senate Committee on Finance to repeal the medical device tax
• Letter to the House and Senate Labor, Health and Human Services, Education and Related Agencies Appropriations Subcommittee leadership to increase funding for the NIH, CDC and AHRQ in the FY16 budget
• Letter to the House and Senate Commerce, Justice and Science Appropriations Subcommittee leadership to increase funding for the NSF in the FY16 budget
• Letter to the House and Senate Agriculture Appropriations Subcommittee leadership to increase funding for the FDA in the FY16 budget

October

• Joint Statement by the Aerospace Industries Association, the National Defense Industrial Association, Research!America and United for Medical Research urging Congress to lift discretionary spending caps
• Letter to the Committee on Health, Education, Labor and Pensions leadership on Innovations for Healthier Americans

May

• Letter to the Committee on Energy & Commerce commenting on the NIH Innovation Fund

April

• Letter to the Conference Committee for the Fiscal Year 2016 budget resolution
• Testimony of Research!America to the Senate Committee on Finance Subcommittee on Health Care
• Letter to the Committee on Science, Space and Technology commenting on the America COMPETES Reauthorization Act of 2015 (H.R. 1806)
• Letter to the Committee on Appropriations commenting on increased funding for NIH, CDC and AHRQ as part of Appropriations 302(b)
• Testimony of Research!America to the House Committee on Appropriations Subcommittee on
  Labor, Health and Human Services, Education, and Related Agencies
• Testimony of Research!America to the House Committee on Appropriations Subcommittee on Commerce, Justice, Science, and Related Agencies Concerning FY16 Appropriations for NSF

March

• Letter to Members of Congress regarding Research!America's FY16 Appropriations Request
• Testimony to the House Committee on Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies for the Budget Hearing on the National Institutes of Health

February

• Statement for the record of the House Committee on Ways and Means' markup of H.R. 880, a bill to amend the Internal Revenue Code of 1986 to simplify and make permanent the research credit. 

2014

November

• Letter to congressional leaders urging them to pass an omnibus appropriations bill that boosts funding for NIH, CDC, FDA, AHRQ and NSF
• Testimony Before the Senate Appropriations Committee Hearing titled "U.S. Government Response: Fighting Ebola and Protecting America"

May

• Testimony to the Senate Committee on Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies Concerning FY15 Appropriations for the NIH, CDC and AHRQ

February

• Letter to appropriators thanking them for the funding increase provided to the FDA in the Consolidated Appropriations Act of 2014

January

• Letter to the President urging him to champion medical and health research in the FY15 budget